Nolasiban Uses, Dosage, Side Effects and more
Nolasiban is under investigation in clinical trial NCT03081208 (Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI).
| Trade Name | Nolasiban |
| Generic | Nolasiban |
| Nolasiban Other Names | Erlosiban, Nolasiban |
| Type | |
| Formula | C20H22N2O3 |
| Weight | Average: 338.407 Monoisotopic: 338.163042576 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
